Lv11
40 积分 2025-10-29 加入
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
3小时前
待确认
De novo design of miniproteins targeting GPCRs
1个月前
已完结
The past, present and future of de novo protein design
2个月前
已完结
DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design
2个月前
已完结
GalaxyDock-DL: Protein–Ligand Docking by Global Optimization and Neural Network Energy
3个月前
已完结
PD-1 x CD2 cis-acting bispecific antibodies are potent PD-1 agonists that restrain human T cell responses independent of Fc-receptor engagement 4271
6个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
6个月前
已完结
Surface Charge and Solvent Exposure Dictate the pH-Dependent Viscosity of Therapeutic Antibodies
6个月前
已完结
Simulating 500 million years of evolution with a language model
7个月前
已完结
AI-driven antibody design with generative diffusion models: current insights and future directions
7个月前
已完结
皖公网安备34019202002308
